Business
OBIO® Paves the Way for Companies to Succeed in Canada as a Stepping Stone to New Global Markets
TORONTO, July 16, 2025--OBIO®, a not-for-profit, membership-based organization offering programming and infrastructure to support early-stage and venture-backed companies, announces the launch of its Health Commercialization Access Program to accelerate the growth of Canadian biotechnology and health technology companies. The Program is supported by the Government of Canada, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), as part of a $5-million investment
About this update from Orchestra Biomed Holdings, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1563,"height":432,"url":"https://mms.businesswire.com/media/20250716618378/en/2524355/5/OBIO_Logo_DarkGradient-2_for_light_background.jpg"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.QCf2hi185jWRPVtBUhoHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI2NTtjZj13ZWJw/https://mms.businesswire.com/media/20250716618378/en/2524355/5/OBIO_Logo_DarkGradient-2_for_light_background.jpg","width":960,"height":265},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/NSsKOh1l_5rDBhRl10vLgQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02NjQ7Y2Y9d2VicA--/https://mms.businesswire.com/media/20250716618378/en/2524355/5/OBIO_Logo_DarkGradient-2_for_light_background.jpg","width":1200,"height":332}},"lazy":false},{"type":"text","content":"TORONTO, July 16, 2025--(BUSINESS WIRE)--OBIO®, a not-for-profit, membership-based organization offering programming and infrastructure to support early-stage and venture-backed companies, announces the launch of its Health Commercialization Access Program to accelerate the growth of Canadian biotechnology and health technology companies. The Program is supported by the Government of Canada, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), as part of a $5-million investment in OBIO®.","length":526,"tagName":"p"},{"type":"text","content":"FedDev Ontario has long championed OBIO® to assist high-potential health and life sciences companies to grow, scale up and attract global investment. Over the past decade, OBIO® has enabled over 350 companies to generate in excess of $150 million in sales and $200 million in foreign direct investment. Through its Early Adopter Health Network (EAHN™) and by accelerating technology commercialization, post-seed financing and strategic partnerships via its Capital Access Advisory Program (CAAP®), OBIO® has been helping Canadian innovators establish a beachhead in our publicly-funded healthcare systems.","length":605,"tagName":"p"},{"type":"text","content":"Through its programming, OBIO® identifies early-stage companies that are well-positioned to develop their businesses in Canada and expand to countries on other continents. OBIO’s EAHN™ program, which includes more than 80 healthcare organizations and health systems across Canad...